HMGB1 and type 1 diabetes mellitus: Sodium butyrate inhibited the expression of HMGB1 and NF-κB proteins in the pancreas and suppressed the progression of T1DM by inhibiting HMGB1 and downregulating the NF-κB-mediated inflammatory signaling pathways (Guo et al. 2018).